Xavier Amiot

1.9k total citations · 1 hit paper
34 papers, 880 citations indexed

About

Xavier Amiot is a scholar working on Hepatology, Epidemiology and Surgery. According to data from OpenAlex, Xavier Amiot has authored 34 papers receiving a total of 880 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Hepatology, 12 papers in Epidemiology and 11 papers in Surgery. Recurrent topics in Xavier Amiot's work include Liver Disease and Transplantation (11 papers), Liver Disease Diagnosis and Treatment (8 papers) and Hepatitis C virus research (7 papers). Xavier Amiot is often cited by papers focused on Liver Disease and Transplantation (11 papers), Liver Disease Diagnosis and Treatment (8 papers) and Hepatitis C virus research (7 papers). Xavier Amiot collaborates with scholars based in France, United Kingdom and Switzerland. Xavier Amiot's co-authors include Jean‐Didier Grangé, Thierry Poynard, Eric Nguyen Khac, P Opolon, Brigitte Bernard, Gilles Pelletier, Antoine Flahault, E A Pariente, Jacques Denis and D Fischer and has published in prestigious journals such as Gastroenterology, Hepatology and The American Journal of Medicine.

In The Last Decade

Xavier Amiot

26 papers receiving 845 citations

Hit Papers

Antibiotic Prophylaxis for the Prevention of Bacterial In... 1999 2026 2008 2017 1999 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xavier Amiot France 8 768 673 375 82 52 34 880
Janaína Luz Narciso-Schiavon Brazil 18 678 0.9× 680 1.0× 134 0.4× 50 0.6× 56 1.1× 83 966
Adolfo Gallego Spain 13 670 0.9× 607 0.9× 370 1.0× 139 1.7× 16 0.3× 28 849
Javier Solá-Vera Spain 14 525 0.7× 520 0.8× 451 1.2× 45 0.5× 78 1.5× 24 1.0k
Ulrich Thalheimer United Kingdom 19 989 1.3× 903 1.3× 490 1.3× 51 0.6× 44 0.8× 34 1.2k
A. Pardo Spain 5 420 0.5× 366 0.5× 203 0.5× 27 0.3× 30 0.6× 11 503
S. Angeloni Italy 15 1.4k 1.9× 1.3k 1.9× 928 2.5× 114 1.4× 40 0.8× 20 1.6k
Silvia Montoliu Spain 9 1.1k 1.4× 951 1.4× 392 1.0× 22 0.3× 63 1.2× 19 1.2k
B.A. Payer Austria 22 1.4k 1.8× 1.4k 2.0× 412 1.1× 46 0.6× 135 2.6× 42 1.6k
A. Rimola Spain 14 775 1.0× 568 0.8× 496 1.3× 16 0.2× 141 2.7× 47 1.1k
Albert Pardo Spain 9 473 0.6× 449 0.7× 411 1.1× 166 2.0× 44 0.8× 26 799

Countries citing papers authored by Xavier Amiot

Since Specialization
Citations

This map shows the geographic impact of Xavier Amiot's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xavier Amiot with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xavier Amiot more than expected).

Fields of papers citing papers by Xavier Amiot

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xavier Amiot. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xavier Amiot. The network helps show where Xavier Amiot may publish in the future.

Co-authorship network of co-authors of Xavier Amiot

This figure shows the co-authorship network connecting the top 25 collaborators of Xavier Amiot. A scholar is included among the top collaborators of Xavier Amiot based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xavier Amiot. Xavier Amiot is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bachmeyer, Claude, et al.. (2023). Recent-Onset Diabetes Mellitus and Paraneoplastic Hypercalcemia Revealing Adenosquamous Carcinoma of the Pancreas. The American Journal of Medicine. 136(8). e157–e158. 3 indexed citations
2.
Daudon, Michel, et al.. (2022). Features of gallstones in adult sickle cell patients. Comptes Rendus Chimie. 25(S1). 535–552.
3.
Beaugerie, Laurent, Franck Carbonnel, Anne Bourrier, et al.. (2020). Real-world use of therapeutic drug monitoring of CT-P13 in patients with inflammatory bowel disease: A 12-month prospective observational cohort study. Clinics and Research in Hepatology and Gastroenterology. 44(4). 609–618. 5 indexed citations
4.
Amiot, Xavier, Isabelle Ollivier‐Hourmand, Christophe Renou, et al.. (2019). Efficacy and safety of treatment of chronic hepatitis C with sofosbuvir and ribavirin with or without peginterferon: a French prospective real-life cohort study of unselected 211 patients. European Journal of Gastroenterology & Hepatology. 31(10). 1270–1274. 1 indexed citations
5.
Amiot, Xavier, et al.. (2018). Brucellose avec abcès hépatiques : un diagnostic à ne pas oublier. La Revue de Médecine Interne. 40(1). 43–46. 1 indexed citations
6.
Verdet, Charlotte, et al.. (2017). No Neck Pain: Meningococcemia. The American Journal of Medicine. 131(1). 37–40. 4 indexed citations
7.
Paclet, Marie‐Hélène, et al.. (2016). Élévation isolée des aspartates aminotransférases chez une patiente asymptomatique. La Presse Médicale. 46(1). 138–139.
8.
Nathan, Nadia, Odile Macchi, Rola Abou Taam, et al.. (2015). Inorganic exposome in pediatric sarcoidosis: The PEDIASARC study. PA849–PA849. 1 indexed citations
9.
Amiot, Xavier, et al.. (2009). Treatment of chronic hepatitis C in sickle cell disease and thalassaemic patients with interferon and ribavirin. European Journal of Gastroenterology & Hepatology. 21(7). 726–729. 13 indexed citations
10.
Amiot, Xavier. (2004). Comment traiter une ascite réfractaire ?. Gastroentérologie Clinique et Biologique. 28. 123–129. 1 indexed citations
11.
Amiot, Xavier, et al.. (2004). Nitric oxide and renal function in cirrhotic patients with ascites. European Journal of Gastroenterology & Hepatology. 16(6). 567–570. 12 indexed citations
12.
Grangè, Jean Didier, J.-M. Antoine, & Xavier Amiot. (1999). [Hepatitis C virus and pregnancy].. PubMed. 23(10). 1033–9. 3 indexed citations
13.
Grangè, Jean Didier, et al.. (1998). Antibiotic Prophylaxis for the Prevention of Bacterial Infections in Cirrhotic Patients with Ascites: A Meta-Analysis. Digestion. 59(Suppl. 2). 54–57. 27 indexed citations
14.
Roulot, Dominique, Gilles Pelletier, E A Pariente, et al.. (1998). Norfloxacin primary prophylaxis of bacterial infections in cirrhotic patients with ascites: a double-blind randomized trial. Journal of Hepatology. 29(3). 430–436. 127 indexed citations
15.
Grangé, Jean‐Didier, Armand Abergel, Xavier Amiot, et al.. (1995). [Interactions between chronic viral hepatitis C and pregnancy].. PubMed. 19(5). 520–4. 10 indexed citations
16.
Grangé, Jean‐Didier, et al.. (1995). Survival after a first episode of spontaneous bacterial peritonitis. Prognosis of potential candidates for orthotopic liver transplantation. Journal of Gastroenterology and Hepatology. 10(1). 47–50. 61 indexed citations
17.
Lotz, Jean‐Pierre, Jean‐Didier Grangé, L Hannoun, et al.. (1994). Treatment of unresectable hepatocellular carcinoma with a combination of human recombinant α-2b interferon and doxorubicin: Results of a pilot study. European Journal of Cancer. 30(9). 1319–1325. 6 indexed citations
18.
Grangé, Jean‐Didier & Xavier Amiot. (1992). [Prophylaxis of infectious complications by selective digestive bacterial decontamination in patients with cirrhosis].. PubMed. 16(8-9). 692–700. 7 indexed citations
20.
Grangé, Jean‐Didier, Alain Gouyette, Ludwig Gutmann, et al.. (1989). Pharmacokinetics of amoxycillin/clavulanic acid in serum and ascitic fluid in cirrhotic patients. Journal of Antimicrobial Chemotherapy. 23(4). 605–611. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026